Azapeptides as pharmacological agents

被引:73
作者
Zega, A [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, SI-1000 Ljubljana, Slovenia
关键词
azapeptides; conformational properties; biological action; peptidomimetics;
D O I
10.2174/0929867053362802
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Azapeptides, formed by replacing the C-alpha of amino acid residues by nitrogen, are promising peptidomimetic compounds. Azaamino acids impart a unique conformational property to peptide structures because of the loss of chirality and reduction of flexibility of the parent linear peptide. The peculiar conformational properties make azaamino acids an attractive tool for drug design involving specific secondary structures in peptides and proteins. Additionally, since azapeptides are less susceptible to enzymatic breakdown by proteases, they may possibly lead to orally active drugs with longer duration of action. One of the advantages of azapeptides is their unproblematic synthesis allowing retention of the amino acid side chain. Azapeptides have been developed by several groups for the design of hormone analogues, protease inhibitors and active site titrants.
引用
收藏
页码:589 / 597
页数:9
相关论文
共 93 条
[1]  
Andre F, 1997, J PEPT SCI, V3, P429, DOI 10.1002/(SICI)1099-1387(199711)3:6<429::AID-PSC115>3.0.CO
[2]  
2-C
[3]  
Andre F, 1997, J PEPT RES, V49, P556
[4]  
Andre F, 1997, J PEPT RES, V50, P372
[5]   Synthesis and structural studies of aza analogues of functionalized amino acids:: New anticonvulsant agents [J].
Andurkar, SV ;
Béguin, C ;
Stables, JP ;
Kohn, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (09) :1475-1478
[6]   Aza-peptide epoxides: A new class of inhibitors selective for clan CD cysteine proteases [J].
Asgian, JL ;
James, KE ;
Li, ZZ ;
Carter, W ;
Barrett, AJ ;
Mikolajczyk, J ;
Salvesen, GS ;
Powers, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :4958-4960
[7]  
Bac A, 1997, LETT PEPT SCI, V4, P251, DOI 10.1007/BF02442885
[8]   New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors:: Candidates for clinical development [J].
Bold, G ;
Fässler, A ;
Capraro, HG ;
Cozens, R ;
Klimkait, T ;
Lazdins, J ;
Mestan, J ;
Poncioni, B ;
Rösel, J ;
Stover, D ;
Tintelnot-Blomley, M ;
Acemoglu, F ;
Beck, W ;
Boss, E ;
Eschbach, M ;
Hürlimann, T ;
Masso, E ;
Roussel, S ;
Ucci-Stoll, K ;
Wyss, D ;
Lang, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3387-3401
[9]   Synthesis and evaluation of azaproline peptides as potential inhibitors of dipeptidyl peptidase IV and prolyl oligopeptidase [J].
Borloo, M ;
Augustyns, K ;
Belyaev, A ;
deMeester, I ;
Lambeir, AM ;
Goossens, F ;
Bollaert, W ;
Rajan, P ;
Scharpe, S ;
Haemers, A .
LETTERS IN PEPTIDE SCIENCE, 1995, 2 (3-4) :198-202
[10]   IDENTITY OF TRYPTIC AND ALPHA-CHYMOTRYPTIC REACTIVE SITES ON SOYBEAN TRYPSIN-INHIBITOR (KUNITZ) [J].
DEVONISB.U ;
LEARY, TR ;
LASKOWSKI, M .
BIOCHEMISTRY, 1972, 11 (17) :3303-+